2. Start-up in Focus
2013.09.22 Manu Sharma - Japan
Biocon
Biopharma Enterprise focussed on
INNOVATION
to deliver
‘AFFORDABLE
HEALTHCARE’
3. Start-up in Focus
2013.09.22 Manu Sharma - Japan
Biocon
Idea behind this Start-up as stated by Founder
‘FOOLISH
COURAGE’
to pioneer in a novel field of
‘BIOTECHNOLOGY’
4. Biocon – What is it?
2013.09.22 Manu Sharma - Japan
Syngene and Clinigene are the subsidiaries of Biocon
5. Biocon – The Story so far?
2013.09.22 Manu Sharma - Japan
7. Biocon – Factors contributing to its success
2013.09.22 Manu Sharma - Japan
1
Seizing
‘OPPORTUNITY’
,right one at the right time!!!
8. Biocon – Factors contributing to its success
2013.09.22 Manu Sharma - Japan
1 ‘OPPORTUNITY’
was TIMELY
was SOLVABLE
was IMPORTANT
was PROFITABLE
was in CONTEXT
9. Biocon – Factors contributing to its success
2013.09.22 Manu Sharma - Japan
2
Having
‘CAPABILITY’
Knowledge, Skill and Education!!!
10. Biocon – Factors contributing to its success
2013.09.22 Manu Sharma - Japan
2 Founder had
‘CAPABILTY’
by EDUCATION
by SKILL
by EXPERIENCE
by ATTITUDE
by VISION
11. Biocon – Factors contributing to its success
2013.09.22 Manu Sharma - Japan
3
Having
‘VISION’
backed by robust Business Model!!!
12. Biocon – Factors contributing to its success
2013.09.22 Manu Sharma - Japan
3 Aligned
‘VISION’
with CAPABILITIES
with SUSTAINANCE
with MARKET NEED
with BUSi.PLAN
13. Biocon – Factors contributing to its success
2013.09.22 Manu Sharma - Japan
4
Applying
‘INNOVATION’
Consistently with proper Methodologyl!!!
14. Biocon – Factors contributing to its success
2013.09.22 Manu Sharma - Japan
4 Applying
‘INNOVATION’
15. Biocon – Factors contributing to its success
2013.09.22 Manu Sharma - Japan
5
Purpose to be
‘HUMANITARIAN’
Striving for betterment of People and
Environment!!!
16. Biocon – Factors contributing to its success
2013.09.22 Manu Sharma - Japan
5
Purpose
‘HUMANITARIAN’
being LOCAL
yet GLOBAL
Biocon is committed to reduce therapy costs of chronic
diseases like DIABETES, CANCER and
AUTOIMMUNE diseases by leveraging India's cost
advantage to deliver affordable healthcare solutions to
patients, partners and healthcare systems across the
GLOBE.
17. References
2013.09.22 Manu Sharma - Japan
1. http://en.wikipedia.org/wiki/Kiran_Mazumdar-Shaw
2. www.biocon.com
3. Investors’ Presentation “Biocon_IRPrstn_July2013”
4. Technology Ventures – from Idea to Enterprise by
Thomas H. Byers Stanford University, Richard C. Dorf
University of California, Davis Andrew J. Nelson, University of
Oregon